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ABSTRACT
The present report shows the occurrence of thrombotic thrombocytopenic purpura (TTP) 
associated with acute dengue and chikungunya virus coinfection, manifesting as a severe 
disease with high mortality potential. The patient was a 28 year-old man with clinical and 
epidemiological diagnosis of arboviruses infections who developed thrombocytopenia and 
anemia, after which oral corticosteroid therapy was started. On the third day of hospitalization, 
he showed neurological alterations that simulated a cerebral vascular accident, but the imaging 
examination did not identify ischemic or hemorrhagic alterations. At that moment, the TTP 
hypothesis was raised so that plasmapheresis and corticosteroid pulse therapy were started, 
have been essential for the favorable evolution of the case.
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INTRODUCTION
Thrombotic microangiopathies (TMA) are a heterogeneous group of potentially 
fatal diseases1-4. The most severe short-term TMA is thrombotic thrombocytopenic 
purpura (TTP)2. The pathophysiology of this disease is due to the formation of 
microthrombi in the endothelium due to platelet hyperaggregation to the non-
cleaved von Willebrand factor (VWF) 1 multimers. ADAMTS13 (a disintegrin and 
metalloproteinase with a thrombospondin type 1 motif, member 13) is the protein 
responsible for the cleavage of vWF multimers. Its deficiency may be congenital 
(cTTP) or acquired, usually of autoimmune origin1-4.
Acquired TTP is usually mediated by anti-ADAMTS13 antibodies or 
immune mediated Thrombotic Thrombocytopenic Purpura (iTTP). It presents 
as microangiopathic hemolytic anemia, thrombocytopenia and neurological 
alterations2. The presentation is acute in most cases and invariably fatal, if not 
treated adequately3.
Infections are important causes of immune responses in the context of iTTP5. 
Reports of TTP secondary to parvovirus B19, dengue, HIV and viral hepatitis 
demonstrate the potential of viral infections to act as a triggering factor of 
microangiopathic diathesis6-9. The present case report describes iTTP secondary 
to dengue and chikungunya virus coinfection in the current epidemic of arbovirus 
infections in a State in Northeastern Brazil.
Bastos et al.
Rev Inst Med Trop São Paulo. 2018;60:e48Page 2 of 4
CASE REPORT
A 28-year-old male patient with a previous history of 
immune thrombocytopenic purpura (ITP), diagnosed six 
years ago but had stopped had treatment approximately five 
years ago, was hospitalized with clinical and epidemiological 
diagnosis of arbovirus infection (fever, asthenia, myalgia 
and arthralgia). On admission, thrombocytopenia 
(12,000/mm3) and anemia (8.0 g/dL) were observed (Table 1). 
Oral corticosteroid therapy was started with prednisone 
1 mg/kg/day. On the third day of hospitalization, he had 
headache with vomiting, associated with mental confusion 
and, subsequently, motor aphasia and right hemiplegia. 
Considering the sudden worsening of the patient’s overall 
conditions, he was referred to the intensive care unit. Nuclear 
magnetic resonance imaging of the brain was performed 
to rule out acute ischemic or hemorrhagic events. The 
neuroimaging examination showed no alterations. Faced 
with an acute neurological worsening, the possibility of TTP 
was considered. Analysis of the peripheral smear showed 
innumerable schizocytes, confirming the presence of TMA. 
Plasmapheresis and pulse therapy with methylprednisolone 
were started due to the hypothesis of TTP.
Serological results were IgM positive for chikungunya 
and dengue viruses, and initially, the presence of IgG only 
raised to chikungunya virus (Euroimmun Medizinische 
Labordiagnostika, Lübeck, Germany). Serological tests 
for hepatitis virus B and C were negative, as well as for 
retroviruses (only HIV). Regarding retroviruses, other 
representatives are not routinely investigated and, in this 
case, they were not suspected. The patient also had negative 
results for antinuclear antibody (ANA) (Table 2). During the 
follow-up, serological results for dengue and chikungunya 
were confirmed, at this time showing the presence of IgG 
antibodies to chikungunya as well as to dengue virus. The 
serological test for zika virus was not performed following 
guidelines from Brazilian Ministry of Health, which 
recommend not to test zika virus when serological tests for 
dengue and chikungunya are positive.
There was a decrease in lactate dehydrogenase (LDH) 
(Table 1). Plasmapheresis was maintained until platelet 
counts remained higher than 150,000 for three consecutive 
days (Figure 1). Complete remission of neurological signs 
occurred after the first plasmapheresis.
DISCUSSION
There have been rare descriptions in the literature of 
TTP association with chikungunya fever, or coinfection 
Table 1 - Temporal evolution of Hb (g / dL), platelets (/ mm³) and LDH (U / L). On the 5th day, the plasma exchange started
D0 D3 D6 D7 D8 D9 D10 D11 D12 D13 D17
Hb (g/dL) 8.0 6.4 6.3 7.4 7.3 7.8 9.5 9.9 10.6 11.6 10.3
Platelets (/mm³) 12.000 11.000 34.000 54.000 105.000 156.000 202.000 239.000 301.000 398.000 366.000
LDH (U/L) 1.166 1.461 660 445 775 481 364 444 339
Reticulocyte (relative %) 1,9 6
*Reference value: Hb = 13,5-18,0 g/dL; Platelets = 140.000- 450.000; LDH = 200 -480 U/L; Reticulocyte count relative (%) = 0,5 – 2,3
Figure 1 - Platelets (/mm³) from the day of arrival until discharge. 
The patient underwent plasmapheresis from day 2 to day 5
Table 2 - Serologic assessment showing the presence of 
IgM/IgG anti CHIKV and IgM antiDen. ADAMTS13 low activity 
and the presence of an inhibitor confirms the diagnosis of TTP 
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with other arboviruses, such as dengue virus6-9. The aim 
of this publication is to provide data for further studies and 
alert health teams to identify arboviruses-related emergency 
associations.
This case report describes a severe hematological 
complication associated with emerging arboviruses, such 
as chikungunya virus, which is endemic in Brazil in a 
coinfection with dengue virus. The patient was admitted with 
unspecific symptoms, including fever, myalgia and arthralgia, 
which is common to the three currently endemic arboviruses 
in Brazil. As the symptomatology is not specific of any of 
the three arboviruses, they may vary from patient to patient, 
in most cases only serological tests can differentiate one 
infection from another, according to the current literature10.
The formation of anti-ADAMTS13 antibodies has 
been implicated in the genesis of many cases of acquired 
TTP4. In this context, infections are important triggers 
for microangiopathic diathesis5. The patient had TMA-
compatible clinical manifestations. The presence of acute 
neurological alterations is compatible with TTP. In addition, 
serological results together with clinical manifestations and 
the occurrence of arboviruses epidemic in Northeastern 
Brazil confirm the diagnosis of dengue and chikungunya 
virus coinfection in this case. 
Chikungunya fever is a disease spread by mosquitos 
of the Aedes aegypti genus. It belongs to the genus 
alphavirus, has RNA as its genetic material and enters host 
cells through the envelope of glycoproteins, especially E1 
and E2. The first cases were described in 1952-1953 in 
Africa5. The disease symptomatology is most often joint-
related, with a recent description of potentially severe 
neurological and immunological phenomena such as 
encephalitis5, Guillain-Barré syndrome5,11 and immune-
mediated thrombocytopenia11. The arrival of the virus in 
Brazil was probably due to the 2014 World Cup, when zika 
and chikungunya viruses became part of the arboviruses 
circulating in the country5.
Dengue fever is an endemic disease in Northeast Brazil, 
with episodes of cyclic epidemics, especially during the rainy 
season at the beginning of each year. It is also transmitted 
by mosquitos11. It belongs to the genus flavivirus and has 
RNA as its genetic material. The infection is most often 
asymptomatic, with some patients developing arthralgia, 
thrombocytopenia and episodes of vascular extravasation, 
which, if not adequately managed, can progress to severe 
forms. Dengue may be associated with neurological and 
hematological complications12, among others.
The two arboviruses infections may present with myalgia, 
headache, arthralgia and thrombocytopenia. Anemia is not 
a common finding for these diseases12,13. Coinfection can 
occur, especially because the two viruses share the same 
vector, the Aedes aegypti mosquito. TTP cases were reported 
in association with dengue fever6,7 and Congo-Crimean 
hemorrhagic fever with chikungunya infection8.
Severe deficiency of the ADAMTS 13 protein (defined 
as activity below 10%) plays an important role in the genesis 
of TTP. This proteinase cleaves the vWF multimer, which 
participates in the coagulation and platelet aggregation 
pathways1.
In this case, the patient was at first clinically and 
epidemiologically diagnosed with an arbovirus infection 
due to the dengue and chikungunya fever epidemic in 
Northeastern Brazil. Subsequently, worsening of anemia, 
thrombocytopenia, neurological alterations and the presence 
of schizocytes in the peripheral blood smear suggested the 
diagnosis of TMA7,8. The ADAMTS 13 activity below 10% 
and positive serological tests (IgM and IgG) to dengue 
and chikungunya confirmed the arboviruses coinfection 
associated with iTTP secondary to the arboviruses infections. 
CONCLUSION
Although there is a lot of information on hematological 
complications of dengue virus infections, there same is not 
true regarding chikungunya virus infections. In this context, 
due to the severity and lethality of TTP, it is important that 
health professionals are prepared to identify similar cases 
and that adequate therapy is instituted in a timely manner. 
More studies are required to evaluate the impact of dengue 
and chikungunya virus infection on the genesis of TMA, 
especially TTP.
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